Health Canada approves Estelle as first native estrogen-based combined oral contraceptive March 9, 2021
CAUSALITY study of Xla-1 shows safety in healthy volunteers and starts enrolling obese patients March 8, 2021
Eli Lilly presents promising data from SURPASS-2 study of tirzepatide in type 2 diabetes March 5, 2021
Positive phase I data support advancing FOR-6219 to phase II development in endometriosis March 5, 2021
RSS